AVL9 promotes colorectal carcinoma cell migration via regulating EGFR expression

BACKGROUND: Despite advanced treatments could inhibit progression of colorectal carcinoma (CRC), the recurrence and metastasis remain challenging issues. Accumulating evidences implicated that AVL9 played a vital role in human cancers, but it’s biological function and mechanism in CRC remain unclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qiong, Chen, Jing De, Zhou, Zhuqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903581/
https://www.ncbi.nlm.nih.gov/pubmed/34991461
http://dx.doi.org/10.1186/s12575-021-00162-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903581/
https://www.ncbi.nlm.nih.gov/pubmed/34991461
http://dx.doi.org/10.1186/s12575-021-00162-8

Ejemplares similares